Accolades
Sidley Deal Honored at D CEO Mergers & Acquisitions Awards
May 14, 2024
Avantax’s US$1.2 billion take-private sale to Cetera won “Deal of the Year” in the $1 Billion + category at D CEO’s Mergers & Acquisitions Awards 2024. Sidley represented Avantax, Inc. (NASDAQ:AVTA), a leader in tax-focused financial planning and wealth management, in its acquisition by Aretec Group, Inc., d/b/a Cetera Holdings, the holding company of Cetera, a financial adviser Wealth Hub. Under the terms of the agreement, holders of Avantax common stock received US$26.00 in cash per share, without interest and subject to required withholding taxes. The all-cash transaction closed in November 2023. The Sidley deal team was led by M&A partners Beth E. Berg and Scott R. Williams.
Additionally, Bill Howell, a partner in Sidley’s Dallas office, was a finalist for “Attorney of the Year” at D CEO’s Mergers & Acquisitions Awards 2024. The annual Mergers & Acquisitions Awards, now in their 11th year, honor the “top acquisitions, dispositions, and other financial transactions in North Texas in 2023 - and the dealmakers who made them happen.”
Additionally, Bill Howell, a partner in Sidley’s Dallas office, was a finalist for “Attorney of the Year” at D CEO’s Mergers & Acquisitions Awards 2024. The annual Mergers & Acquisitions Awards, now in their 11th year, honor the “top acquisitions, dispositions, and other financial transactions in North Texas in 2023 - and the dealmakers who made them happen.”
Contacts
Offices
Capabilities
Suggested News & Insights
Sidley Represents Churchill Downs in Its Acquisition of Preakness Intellectual Property RightsApril 22, 2026Sidley Represents ModMed in Its Acquisition of Bonsai HealthApril 22, 2026Sidley Represents Cboe Global Markets in Its US$300 Million Sale of Cboe Australia and Cboe Canada to TMX GroupApril 22, 2026Bad Investments, Not Bad Faith: Caremark Claims Have LimitsApril 21, 2026Sidley Represents Opus Genetics in US$155 Million Financing With Oberland CapitalApril 21, 2026Sidley Represents Galera Therapeutics in Its Merger With Obsidian Therapeutics and US$350 Million Private Placement FinancingApril 21, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory


